Indications for use
The indication is suspicion of ovarian cancer and the different patient groups are:
a) Confirmation test. Women under investigation at various care units as well are being referred to hospitals with suspicion of ovarian cancer.
b) Monitoring during treatment and suspicion of recurrence after completion of primary treatment (follow-up). Number of women is the same for group a) even if number of tests will be more.
c) Screening Test. The number of women in the age group is around 1.7 million in Sweden. Indications also include women with positive mammography findings. Given the genetic linkage of breast cancer to ovarian cancer, testing of breastcancer patients may have a preventive effect.